The start of a new wave: Developments in proteasome inhibition in multiple myeloma-Reference-Cited by-同舟云学术

The start of a new wave: Developments in proteasome inhibition in multiple myeloma

Published:2018-05-02 Issue:2 Volume:101 Page:220-236
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Yong Kwee¹,Gonzalez-McQuire Sebastian²^ORCID,Szabo Zsolt²,Schoen Paul²,Hajek Roman³⁴

Affiliation:

1. Department of Haematology; University College Hospital; London UK

2. Amgen (Europe) GmbH; Zug Switzerland

3. University Hospital Ostrava; Ostrava Czech Republic

4. Faculty of Medicine; University of Ostrava; Ostrava Czech Republic

Funder

Kim Allcott and Matthew Long of Oxford PharmaGenesis

Amgen (Europe) GmbH

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13071/fullpdf

Reference106 articles.

1. The role of immunotherapy in multiple myeloma;Kocoglu;Pharmaceuticals (Basel),2016

2. Novel strategies to target the ubiquitin proteasome system in multiple myeloma;Lub;Oncotarget,2016

3. Proteasome inhibition as a novel therapeutic target in human cancer;Rajkumar;J Clin Oncol,2005

4. Multiple myeloma;Kyle;Blood,2008

5. Millennium Pharmaceuticals Inc Velcade (bortezomib): highlights of prescribing information 2014 http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021602s040lbl.pdf

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relative Efficacy of Available Proteasome Inhibitors in Preventing Muscle Contractures Following Neonatal Brachial Plexus Injury;Journal of Bone and Joint Surgery;2024-01-09

2. Specific Attenuation of Purinergic Signaling during Bortezomib-Induced Peripheral Neuropathy In Vitro;International Journal of Molecular Sciences;2022-03-29

3. Specific attenuation of purinergic signaling during bortezomib-induced peripheral neuropathy;2022-02-18

4. Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma;Cancers;2022-02-12

5. Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis;Journal of Oncology Pharmacy Practice;2022-02-04